A 3 month old, asymptomatic infant with, H/o TB exposure, has taken 3 months of chemoprophylaxis( isoniazid ), what is to be done next?
**Core Concept**
TB chemoprophylaxis in infants is typically administered for 6 months to prevent the development of active tuberculosis. The goal is to eradicate the latent infection before it progresses to active disease.
**Why the Correct Answer is Right**
In the case of an infant who has completed 3 months of chemoprophylaxis, it is essential to continue treatment for the remaining duration to ensure complete eradication of the latent TB infection. This is because infants have a higher risk of developing TB due to their immature immune system. Continuing isoniazid for the full 6 months will help prevent the development of active TB.
**Why Each Wrong Option is Incorrect**
**Option A:** Discontinuing isoniazid at this point would increase the risk of the infant developing active TB, which can have severe consequences. **Option B:** Switching to a different medication, such as rifampicin, would not be indicated at this stage without consulting a specialist. **Option C:** Administering a different regimen, such as a combination of isoniazid and rifampicin, would be unnecessary and may increase the risk of side effects.
**Clinical Pearl / High-Yield Fact**
It is essential to note that the World Health Organization recommends a 6-month course of isoniazid for the chemoprophylaxis of latent TB in infants exposed to TB. This highlights the importance of adhering to established guidelines to ensure optimal patient outcomes.
**Correct Answer:** C. Continue isoniazid for the full 6 months.